Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis

(MedPage Today) -- A real-world, preprint study in medRxiv found that people with overweight or obesity were up to three times more likely to lose significant weight with tirzepatide (Mounjaro) than with semaglutide (Ozempic), though the study...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news